Business Context and Reporting Period
Company: Psyence Biomedical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of January 2026
Filing Date: January 29, 2026
Principal Executive Office: Toronto, Ontario, Canada
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a cover document for a press release and does not contain embedded financial statements or quantitative data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The document references an attached press release (Exhibit 99.1) dated January 28, 2026, but the content of that release is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. No narrative discussion is present in the cover document itself.
Investor Verification Checklist
- Review the full text of the Press Release dated January 28, 2026 (Exhibit 99.1) referenced in this filing to understand the specific event being reported.
- Verify the company's current financial status through its most recent Form 20-F or interim financial reports, as this filing contains no financial data.
- Confirm the identity of the authorized signatory, Warwick Corden-Lloyd, as Chief Financial Officer.